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ABSTRACT
Background: Short-term exposure to NO2 has been
associated with adverse health effects and there is
increasing concern that NO2 is causally related to
health effects, not merely a marker of traffic-generated
pollution. No comprehensive meta-analysis of the time-
series evidence on NO2 has been published since
2007.
Objective: To quantitatively assess the evidence from
epidemiological time-series studies published
worldwide to determine whether and to what extent
short-term exposure to NO2 is associated with
increased numbers of daily deaths and hospital
admissions.
Design: We conducted a quantitative systematic
review of 204 time-series studies of NO2 and daily
mortality and hospital admissions for several
diagnoses and ages, which were indexed in three
bibliographic databases up to May 2011. We calculated
random-effects estimates by different geographic
regions and globally, and also tested for heterogeneity
and small study bias.
Results: Sufficient estimates for meta-analysis were
available for 43 cause-specific and age-specific
combinations of mortality or hospital admissions
(25 for 24 h NO2 and 18 of the same combinations
for 1 h measures). For the all-age group, a 10 µg/m3
increase in 24 h NO2 was associated with increases in
all-cause, cardiovascular and respiratory mortality
(0.71% (95% CI 0.43% to 1.00%), 0.88% (0.63% to
1.13%) and 1.09% (0.75% to 1.42%), respectively),
and with hospital admissions for respiratory (0.57%
(0.33% to 0.82%)) and cardiovascular (0.66% (0.32%
to 1.01%)) diseases. Evidence of heterogeneity
between geographical region-specific estimates was
identified in more than half of the combinations
analysed.
Conclusions: Our review provides clear evidence of
health effects associated with short-term exposure to
NO2 although further work is required to understand
reasons for the regional heterogeneity observed. The
growing literature, incorporating large multicentre
studies and new evidence from less well-studied
regions of the world, supports further quantitative
review to assess the independence of NO2 health
effects from other air pollutants.
INTRODUCTION
Epidemiological time-series studies have
found associations between daily concentra-
tions of ambient nitrogen dioxide (NO2)
and daily mortality and morbidity out-
comes.1–7 Whether these associations reﬂect
adverse health effects of NO2 has been a
matter of debate.1 The uncertainty about
causality arises largely because of the close
correlations between NO2 and other air pol-
lutants in the mixture of trafﬁc-related pollu-
tants, some of which are more plausible
toxicants. This has led to a view that NO2
may be a surrogate for ﬁne/ultraﬁne particu-
late matter (PM) produced by motor vehicles
and other combustion sources. Despite this
uncertainty, recent narrative reviews of the
evidence linking NO2 with health effects
Strengths and limitations of this study
▪ This is, to date, the most comprehensive, quanti-
tative systematic review of the large time-series
literature on NO2 published worldwide to provide
evidence of associations between short-term
exposure to NO2 and mortality and hospital
admissions for a wide range of respiratory and
cardiovascular diagnoses.
▪ It reports meta-analytical estimates both globally
and for different geographical regions, as well as
an assessment of heterogeneity between the
region-specific estimates.
▪ The protocol-led approach to the identification of
studies and estimates for use in meta-analysis
minimised selection bias at each stage of the
review.
▪ Meta-analysis was limited to studies which pro-
vided effect estimates in numerical, rather than
graphical, form along with sufficient quantitative
data to enable standardisation of estimates.
▪ Further work is needed to understand reasons
for the regional heterogeneity observed and to
quantitatively assess the independence of NO2
health effects from other air pollutants.
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concluded that the epidemiological and toxicological
evidence regarding the pollutant has sufﬁciently
strengthened the likelihood of a causal relationship.1 3
These reviews did not undertake any quantitative assess-
ment of the recent time-series evidence on NO2, but
instead relied on existing meta-analyses, with the last
comprehensive one based on peer-reviewed papers pub-
lished up to the beginning of 2006.6 Since 2006, the
time-series evidence on NO2 has increased substantially,
providing new data from single-city studies and from
inﬂuential multicity studies from less well-studied loca-
tions, for example, Asia,8 9 and from regions previously
examined, for example, Europe and Canada.10 11 The
new data on NO2 will facilitate the calculation of more
robust coefﬁcients for a range of age-speciﬁc and
disease-speciﬁc end points and the examination of
regional variation and heterogeneity. Such quantitative
analyses for NO2 are lacking but are needed for both
hazard and health impact assessments.
We conducted a systematic, quantitative review of the
time-series studies of daily NO2 and daily mortality and
hospital admissions indexed in bibliographic databases
up to May 2011. In this paper, we focus on single pollu-
tant model results to answer the question of whether the
evidence from epidemiological time-series studies sug-
gests adverse associations between short-term exposure
to NO2 and increased numbers of daily deaths and
emergency admissions to hospital. We calculated
meta-analytic estimates for mortality and hospital admis-
sions for several diagnoses and age groups, by different
geographic regions, as well as globally. Whether the asso-
ciations identiﬁed in this review change on adjustment
for the effects of co-pollutants is a different question
which requires analysis of a subset of the studies pre-
sented in this review, that is, studies reporting estimates
of NO2 from single-pollutant and multipollutant models.
A similar review and meta-analysis has been completed
for the subset of studies that reported two-pollutant
model estimates of NO2 adjusted for PM. We intend to
report those ﬁndings in a separate paper.
METHODS
The full methodology and a priori protocols governing
the identiﬁcation of studies and effect estimates for our
systematic review have been described previously, but a
synopsis is provided below.6 12
Identification of studies for review
Bibliographic databases were searched to identify peer-
reviewed time-series papers on NO2 and daily mortality
and hospital admissions indexed up to May 2011.
The search criteria used are shown in the online
supplementary material. Papers suitable for inclusion in
the review were identiﬁed by scanning titles and abstracts
to remove irrelevant citations and then reviewing full
papers of remaining citations. The following inclusion
criteria were applied: papers must (1) have had a
minimum of 1 year of data; (2) be based on the general
population; (3) have controlled for important confound-
ing factors, including season and meteorological factors;
(4) have reported regression estimates and other quanti-
tative data for analysis.
Data extraction and coding
Data from each relevant study were entered into a
Microsoft Access database (Microsoft Ofﬁce 2010,
Microsoft Corporation). These included details of each
publication (authors, journal name, paper title, year
published, etc) and data required for calculating stan-
dardised effect estimates expressed as the percentage
change (and 95% CI) in the mean number of daily
events associated with a 10 µg/m3 increase in NO2 con-
centrations. We entered all outcomes, diagnoses
(International Classiﬁcation of Diseases (ICD) codes),
ages and NO2 concentrations for each reported esti-
mate. We subsequently classiﬁed all reported outcomes,
diseases and ages into a smaller number of diagnostic
categories and age groups to enable meta-analysis of esti-
mates for speciﬁc outcome/disease/age combinations.6
Time-series studies often report results for several dif-
ferent time lags (in days) between exposure and health
events and vary in the lag for the reported results for
outcome/disease/age combinations. To avoid selection
bias, we developed an a priori protocol for identifying
the principal lag for each outcome/disease/age combin-
ation for use in our review. This was the lag highlighted
by the author or stated a priori, and if this was not clear,
because several lagged estimates were reported, we chose
(1) the lag with the highest statistical signiﬁcance, regard-
less of the estimate being positive or negative, or (2) the
lag with the largest estimate, again, irrespective of its dir-
ection.6 If only results from cumulative or distributed lag
models, that is, lags averaged over several days, were
reported in a study, these were used. Further processing
of data included the classiﬁcation of each study into a
geographical region, that is, the WHO region, in which
the study was conducted (see online supplementary
material).
Statistical analyses
We applied an a priori protocol for the selection of esti-
mates for meta-analysis to avoid selection bias and duplica-
tion of studies from the same population. We gave priority
to estimates from multicity studies over estimates from
single-city studies and the results from a city appeared only
once in a meta-analysis. The protocol also gave priority to
the latest publications, the most recent study time periods,
and did not take account of estimates being positive or
negative (see online supplementary material). We only
analysed all-year, single-pollutant model estimates.
Meta-analysis was conducted when ≥4 estimates were
available for an outcome/disease/age combination—
including where a multicity estimate was available—and
summary estimates were calculated using a
random-effects model.13 We used a staged approach to
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meta-analysis, with single-city estimates pooled within
WHO region prior to the pooled single-city and selected
multicity estimates being pooled to produce a global esti-
mate and WHO region-speciﬁc summary estimates.
Heterogeneity between WHO region summary estimates
was assessed using the I2 statistic which describes the
proportion of the variation in effect estimates attribut-
able to between-study variation rather than chance.14
Where estimates permitted, meta-analyses were con-
ducted for both 24 and 1 h average NO2. Finally, we
investigated our selected single-city estimates and our
pooled single-city and selected multicity estimates for evi-
dence of small study bias using the methods of Begg
and Berlin15 and Egger et al.16 We used the trim and ﬁll
technique to adjust the global random-effects estimate
for small study bias where it was detected.17 This tech-
nique estimates and adjusts for the numbers and results
of unreported studies. All analyses were conducted in
STATA (STATA/SE V.11. StataCorp, Texas, USA).
RESULTS
Two hundred and four time-series studies of NO2 and
hospital admissions and mortality indexed in biblio-
graphic databases up to May 2011 were available for
review: a list of references is provided in the online
supplementary material. Table 1 summarises the
numbers of studies stratiﬁed by outcome, broad disease
categories, WHO region, single-city and multicity study
designs, and by averaging time (24 and 1 h). The major-
ity of studies were conducted in Europe, North America
and the WHO Western Paciﬁc region and most used
24 h average concentrations of NO2. There were 123
and 94 studies of mortality and hospital admissions,
respectively, and 42 studies used a multicity design.
Mortality
Sufﬁcient estimates for meta-analysis were available for
seven combinations of all-age, all-cause and cause-speciﬁc
Figure 1 Random-effects summary estimates (95% CIs) for
all-cause and cause-specific mortality in all ages per 10 µg/m3
increase in 24 h NO2 (COPD, chronic obstructive pulmonary
disease).
Table 1 Summary of time-series studies of NO2 and mortality and hospital admissions available for review
Total Multicity study Single-city study
Outcome Mortality*
Hospital
admission Mortality
Hospital
admission Mortality
Hospital
admission
Total 123 94 25 21 98 73
Disease†
Respiratory 70 68 16 12 54 56
Cardiovascular 84 52 18 14 66 38
All-cause 101 4 21 0 80 4
WHO region
American A 24 23 6 5 18 18
European A 56 41 16 11 40 30
Western Pacific B 31 17 2 2 29 15
American B 7 5 0 0 7 5
Western Pacific A 5 7 1 3 4 4
South East Asia B 2 0 2 0 0 0
Averaging time
24 h 107 82 21 17 86 65
Maximum 1 h 27 25 5 10 22 15
*One multicity study on mortality used multiple WHO regions, that is, South East Asia B and Western Pacific B.
†Respiratory includes all respiratory diseases, asthma, COPD (including asthma), lower respiratory infections and upper respiratory diseases;
cardiovascular includes all cardiovascular diseases, cardiac disease, heart failure, ischaemic heart disease, dysrhythmia and stroke.
COPD, chronic obstructive pulmonary disease.
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mortality and 24 h NO2, four of which also provided sufﬁ-
cient estimates for 1 h NO2 for meta-analysis.
Summary estimates for all-cause and cause-speciﬁc
mortality are given in ﬁgure 1, and for all-cause, all car-
diovascular and all respiratory causes, stratiﬁed by WHO
region in table 2. Estimates used in the meta-analyses for
mortality are presented in forest plots in the online sup-
plementary ﬁgures S1–S10. A 10 µg/m3 increase in 24 h
NO2 was associated with a 0.71% (95% CI 0.43% to
1.00%) increase in the risk of death from all causes.
This summary estimate is based on 31 single-city and
multicity estimates selected for meta-analysis from the 84
identiﬁed in the review. Positive associations for all car-
diovascular (0.88% (95% CI 0.63% to 1.13%)) and all
respiratory (1.09% (95% CI 0.75% to 1.42%)) mortality
were also observed, and though based on fewer esti-
mates, we found positive summary estimates for mortal-
ity from other causes, that is, cardiac disease, ischaemic
heart disease, stroke and chronic obstructive pulmonary
disease (COPD) including asthma (ﬁgure 1).
Evidence of high heterogeneity in WHO region-
speciﬁc summary estimates was identiﬁed in more than
half of the mortality combinations (table 2 and see
online supplementary table S1). We regarded an I2 statis-
tic of ≥50% as being evidence of high heterogeneity. The
evidence regarding deaths from cardiac disease, ischae-
mic heart disease, stroke and COPD including asthma
was limited to a small number of WHO regions (see
online supplementary table S1). In general, larger
summary estimates for mortality were found in Europe
and Asia (as WHO regions Europe A, Western Paciﬁc
region and multiregion in table 2 and online supplemen-
tary table S1). Where available, summary estimates for
WHO region America A, that is, USA and Canada, were
consistently smaller than those from other WHO regions
for all mortality combinations examined for 24 h NO2.
The available evidence for 1 h NO2 was smaller in
comparison with that for 24 h NO2. The few available
estimates were mainly limited to the broad mortality
combinations and, with the exception of all-cause mor-
tality, gave comparable summary estimates (table 2).
Hospital admissions
We analysed 18 combinations of cause-speciﬁc and age-
speciﬁc hospital admissions and 24 h NO2, and 14 of the
same combinations for 1 h NO2. Figure 2 presents
Table 2 Meta-analysis results for mortality in all ages associated with a 10 µg/m3 increase in NO2
WHO region
NO2 24 h NO2 1 h
All SC/MC*
Selected
SC/MC†
Random effects
(95% CI)‡ I2 (%)§ All SC/MC*
Selected
SC/MC†
Random effects
(95% CI)‡ I2 (%)§
All-cause, all ages
Overall¶ 72/12 5/6 0.71 (0.43 to 1.00) 61.8 20/3 3/2 0.24 (0.00 to 0.49) 88.2
AMR A 11/5 1/2 0.32 (−0.01 to 0.67) 2/0 2/0 0.76 (−0.05 to 1.58)
AMR B 1/0 1/0 0.59 (−0.26 to 1.45) 2/0 2/0 −0.06 (−0.13, 0.01)
EUR A 40/6 14/3 0.90 (0.45 to 1.35) 14/2 3/1 0.25 (0.10 to 0.40)
WPR A 3/0 3/0 0.66 (−0.10 to 1.44) 2/1 0/1 0.58 (0.21 to 0.94)
WPR B 17/0 6/0 0.56 (0.18 to 0.94) – – –
Multiregion** 0/1 0/1 1.23 (0.84 to 1.62) – – –
All cardiovascular, all ages
Overall¶ 54/8 5/5 0.88 (0.63 to 1.13) 72.7 13/2 1/2 0.85 (0.20 to 1.50) 0
AMR A 5/1 4/1 0.53 (0.38 to 0.67) – – –
AMR B 1/0 1/0 0.73 (−0.87 to 2.36) – – –
EUR A 30/6 10/3 1.03 (0.70 to 1.36) 12/1 2/1 1.02 (−0.44 to 2.49)
WPR A 1/0 1/0 0.67 (−0.24 to 1.60) 1/1 0/1 0.94 (0.42 to 1.47)
WPR B 17/0 7/0 0.91 (0.52 to 1.31) – – –
Multiregion** 0/1 0/1 1.36 (0.89 to 1.83) – – –
All respiratory, all ages
Overall¶ 49/8 5/5 1.09 (0.75 to 1.42) 14.7 16/3 1/2 1.02 (−0.37 to 2.44) 87.4
AMR A 4/1 3/1 0.54 (−0.02 to 1.10) – – –
AMR B 1/0 1/0 1.21 (−1.43 to 3.91) – – –
EUR A 29/6 9/3 1.32 (0.74 to 1.91) 14/2 2/1 0.38 (0.17 to 0.59)
WPR A 3/0 3/0 1.27 (−0.86 to 3.45) 2/1 0/1 2.00 (0.89 to 3.12)
WPR B 12/0 5/0 1.49 (0.47 to 2.52) – – –
Multiregion** 0/1 0/1 1.48 (0.68 to 2.29) – – –
*Numbers of SC/MC estimates available from all studies.
†Numbers of SC/MC estimates selected for meta-analysis.
‡Random-effects summary estimate (95% CI) per 10 μg/m3 increase in NO2.
§I2 statistic for heterogeneity between WHO regions.
¶Estimate numbers for ‘overall’ refer to: (1) the number of SC/MC estimates available from all studies; (2) for selected estimates, it is the
number of pooled (from SC estimates) and MC estimates used to calculate the overall summary estimate across WHO regions.
**Multiregion refers to more than one WHO region. In this table, only one MC study (RMID 313) provided estimates for WHO multiregion for
mortality; the WHO regions covered in this study were SEAR B and WPR B.
AMR, Region of the Americas; EUR, European Region; MC, multicity; SC, single-city; SEAR, South East Asian Region;
WPR, Western Pacific Region.
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summary estimates for hospital admissions and 24 h
NO2. Estimates used in the meta-analyses for hospital
admissions are presented in forest plots in the online
supplementary ﬁgures S11–S39.
We identiﬁed positive associations between 24 h NO2
and admissions to hospital for respiratory diseases.
Based on 15 estimates from ﬁve WHO regions, we found
a 0.57% (95% CI 0.33% to 0.82%) increase in hospital
admissions for all respiratory diseases in all ages asso-
ciated with a 10 µg/m3 increase in 24 h NO2 and no evi-
dence of heterogeneity between WHO region-speciﬁc
estimates (I2=0%). Positive associations with all respira-
tory admissions were also observed in children and the
elderly; asthma in children (1.27% (95% CI 0.28% to
2.27%)); COPD including asthma in the elderly (1.42%
(95% CI 1.07% to 1.76%)); and for COPD in all ages
(1.24% (95% CI −0.01% to 2.50%))—all estimates per
10 µg/m3 increase in 24 h NO2.
For all-age all cardiovascular hospital admissions, the
meta-analysis of seven single-city and multicity study esti-
mates from three WHO regions produced a summary
estimate of 0.66% (95% CI 0.32% to 1.01%). Overall esti-
mates for hospital admissions for speciﬁc cardiovascular-
related diseases in all ages ranged from 0.30% for stroke
admissions to 1.41% for admissions for heart failure, and
in all cases lower CIs were above, or very close to, 0%
(ﬁgure 2). Summary estimates for all 24 h combinations
of cardiovascular-related hospital admissions, except for
stroke, in the elderly were larger than the corresponding
all-age summary estimates, but there was some overlap in
the CIs with those of the all-age combinations (see online
supplementary table S3).
Evidence of high heterogeneity in WHO region-
speciﬁc summary estimates was identiﬁed in more than
half of the 18 combinations of cause-speciﬁc and age-
speciﬁc hospital admissions and 24 h NO2 (see online
supplementary tables S2 and S3).
The available evidence for 1 h NO2 and hospital
admissions was smaller in comparison but showed posi-
tive associations for all combinations examined (see
online supplementary tables S2 and S3).
Small study bias
Table 3 presents results of our assessment of small study
bias in single-city studies within WHO regions and
between the pooled single-city and multicity estimates
for mortality. We restricted this assessment to the broad
mortality combinations as sufﬁcient estimates were avail-
able. With the exception of all respiratory mortality,
there is little evidence of small study bias: adjustment for
the trim and ﬁll technique did not lead to a substantial
reduction in the magnitude of the estimates, and there
was no change in the summary estimate (or 95% CI) for
all cardiovascular mortality. Evidence of small study bias
was found in the multicity studies of respiratory mortality
despite p values of 0.66 and 0.21 for the Begg and Egger
tests, respectively.
DISCUSSION
This systematic review identiﬁed 204 time-series papers
on NO2 and daily mortality and hospital admissions
indexed in bibliographic databases up to May 2011. We
undertook a total of 25 meta-analyses for 24 h NO2 and
combinations of all-age, all-cause and cause-speciﬁc mor-
tality (7) and for disease-speciﬁc and age-speciﬁc hos-
pital admissions (18). Eighteen of the 25 combinations
were also analysed for 1 h NO2. Positive associations
between short-term exposure to NO2 and mortality from
all-cause and cause-speciﬁc diseases and with cardiovas-
cular and respiratory hospital admissions were observed.
Overall, there was evidence of high heterogeneity
between estimates for WHO regions in more than half
of the outcomes examined.
Our quantitative assessment of the literature supports
the conclusions of recent narrative reviews1 3 of the epi-
demiological evidence on NO2 and is also broadly com-
patible with those from the last comprehensive
quantitative review by Anderson et al6 based on time-
series studies published up to the beginning of 2006.
The meta-analyses by Anderson et al used only single-city
estimates, reﬂecting the dominance of this study design
at the time. Our summary estimates now include a
number of multicity studies, which generally applied
standardised methods, conducted in different geograph-
ical regions of the world, as well as newer results from
single-city studies. Our review also reﬂects a growing lit-
erature from outside of North America and Europe,
notably from Asia, with 47 studies identiﬁed by our lit-
erature search up to May 2011. This growth is also
Figure 2 Random-effects summary estimates (95% CIs) for
cause-specific and age-specific hospital admissions per
10 µg/m3 increase in 24 h NO2 (COPD, chronic obstructive
pulmonary disease).
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reﬂected in meta-analyses focusing on data solely from
studies of short-term exposure to air pollution including
NO2 conducted in China.
18 The growth in the time-
series literature since Anderson et al6 permitted an
assessment of a broader range of outcomes in major
depth, and also provides summary estimates not previ-
ously available for some outcomes, for example, cardio-
vascular admissions. It also enables the calculation of
concentration response functions on a more substantial
and broader evidence base increasing conﬁdence in esti-
mated concentration response functions which could be
used in health impact assessment. The broader geo-
graphical representation in time-series studies also sup-
ports application of effect estimates for health impact
assessment from long-term exposure cohort studies on
NO2 based generally in North America and Western
Europe.
We observed high heterogeneity between WHO
region-speciﬁc estimates in more than half of the end
points examined. We hypothesise that these geograph-
ical differences may be due to variations in population
characteristics and in pollution sources, mixtures and
ambient concentrations. However, additional work is
required to investigate potential explanations for this
heterogeneity. In the meantime, quantiﬁcation of the
health impact of short-term exposure to NO2 could
therefore consider the use of local as well as global
summary effect estimates, where a sufﬁcient number of
cities have been analysed.
Our review shows some coherence in terms of the direc-
tion, magnitude and statistical signiﬁcance of the associa-
tions between mortality and hospital admissions for several
diseases examined. There were however much higher esti-
mates for stroke and respiratory mortality than hospitalisa-
tion for these diseases. In general, the interpretation of
mortality versus admissions is problematic because deaths
are coded to the underlying cause whereas admissions are
coded to the cause of admission. In the present case, asso-
ciations between NO2 and stroke mortality could be
explained by effects on respiratory complications rather
than on a mechanism related to stroke itself. It would
require studies in the same population using associated
ICD codes to further investigate this important question.
Comparisons between results for mortality and admissions
may also reﬂect systematic variation in the characteristics
of the studies selected for each meta-analysis.
This review is, to date, the most comprehensive avail-
able for NO2, having worldwide coverage, examining
major outcomes for several diseases and age groups, and
providing meta-analytic estimates both globally and for
speciﬁc geographical regions. A key strength of our
review is the protocol-led approach to identifying studies
and estimates for use in meta-analysis, which also sought
to minimise selection bias in the different stages of the
review. One feature of our approach, in common with
other quantitative reviews, is the requirement that
papers report numerical estimates but some fail to do
so. In some instances, authors may only report statistic-
ally signiﬁcant estimates. A further feature of our review
is the inevitable time delay due to the necessity for
extracting and processing large volumes of data from
the studies. In addition, because our review has world-
wide coverage and did not place any restriction on lan-
guage, translation of some papers was necessary. We
Table 3 Assessment of bias in single-city studies and in pooled estimates for all-cause, all cardiovascular and all respiratory
mortality, in all ages, 24 h NO2
All-cause All cardiovascular All respiratory
Overall estimate no adjustment for bias* 0.71 (0.43 to 1.00) 0.88 (0.63 to 1.13) 1.09 (0.75 to 1.42)
Single-city bias†
WHO region EUR A WPR B EUR A WPR B EUR A WPR B
p Value Begg 0.87 0.57 0.18 0.65 0.68 0.05
p Value Egger 0.41 0.86 0.16 0.89 0.10 0.23
# Estimates 14 6 10 7 9 5
# Trim and fill 14 7 10 7 11 5
Pooled single-city estimate after trim and fill‡ 0.54 (0.31 to 0.77) 0.60 (0.47 to 0.73) 1.16 (0.56 to 1.77)
Multicity bias§
p Value Begg 0.82 0.93 0.66
p Value Egger 0.003 0.12 0.21
# Estimates 11 10 10
# Trim and fill 12 10 15
Overall estimate with adjustment for bias¶ 0.64 (0.36 to 0.92) 0.88 (0.63 to 1.13) 0.80 (0.48 to 1.12)
*Random-effects overall estimate (95% CI) per 10 µg/m3 NO2 (24 h) without adjustment for publication bias.
†Bias in single-city estimates within WHO region: region, Begg’s test p value, Egger’s test p value, number of estimates prior to adjustment for
trim and fill technique, number of estimates after adjustment for trim and fill technique. Assessment of bias in single-city estimates within
WHO region was not conducted in regions providing <5 estimates.
‡Overall pooled singe-city estimate calculated after application of the trim and fill technique to the single-city estimates within WHO region.
§Bias between pooled single-city estimates and multicity estimates, Begg’s test p value, Egger’s test p value, number of estimates prior to
adjustment for trim and fill technique, number of estimates after adjustment for trim and fill technique.
¶Overall pooled estimate calculated after application of the trim and fill technique to single-city estimates within WHO region and between
pooled single-city estimates and multicity estimates.
EUR, European Region; WPR, Western Pacific Region.
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note that studies published since our literature cut-off
date continue to provide evidence of positive associa-
tions between NO2 and daily mortality and hospital
admissions. Recent multicity studies of NO2 and all-
cause mortality reported increases (per 10 μg/m3 NO2)
of 2.09% (95% CI 0.96% to 3.24%) in 10 cities in
Italy;19 1.10% (95% CI 0.63% to 1.58%) in 25 cities in
Italy;20 1.63% (95% posterior interval 1.09% to 2.17%)
in 17 Chinese cities21 and 1.03% ((95% CI 0.91% to
1.18%) per 10 ppb NO2) in 72 US cities.
22 Some of the
cities investigated in these newer multicity studies had
already contributed estimates to the present
meta-analysis.
The causality of adverse health associations of NO2 is
a matter of current debate since there are close correla-
tions between NO2 and other air pollutants in the
mixture of trafﬁc-related pollutants, especially PM.1 The
extent of these correlations varies from city-to-city and
over time, due to variations in the emission sources (eg,
dieselisation of cars and primary production of NO2 by
certain particle traps). Multipollutant models have
been used to attempt to identify effects of NO2 that may
be independent of PM and other co-pollutants. A
previous meta-analysis of multipollutant model estimates
of NO2 indicated a reduction in the pooled estimate
and loss of statistical signiﬁcance following adjustment
for co-pollutants.23 24 However, recent qualitative assess-
ments suggest that the evidence for independent effects
of NO2 is strengthening, but no recent quantitative
analysis of multipollutant model estimates of NO2 has
been undertaken.1 3 6 25 The current meta-analysis con-
centrated on results from single-pollutant models, since
these provided the greatest number of cities, but we
have completed a similar systematic review and
meta-analysis of the subset of studies that reported two-
pollutant model estimates of NO2 adjusted for PM. The
purpose of this second review was to assess the extent to
which the associations identiﬁed in this review change
on adjustment for the effects of PM. We intend to report
those ﬁndings in a separate paper.
Our review has established that there are positive and
statistically signiﬁcant associations between short-term
exposure to NO2 and mortality and hospital admissions
for a range of respiratory and cardiovascular diseases in
different age groups. This comprehensive quantitative
assessment of the time-series evidence on NO2 forms an
important part of understanding whether NO2 contri-
butes to the public health burden of air pollution.
Further work is needed to understand reasons for the
regional heterogeneity observed and to quantitatively
assess the independence of NO2 health effects from
other air pollutants.
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